Carl Ouellet

(<i>S</i>)-(+)-4-[7-(2,2-Dimethyl-1-oxopro- poxy)-4-methyl-2-[4-[2-(1-piperidinyl)- ethoxy]phenyl]-2<i>H</i>-1-benzopyran-3-yl]- phenyl 2,2-Dimethylpropanoate (EM-800):  A Highly Potent, Specific, and Orally Active Nonsteroidal Antiestrogen

Sylvain Gauthier, Brigitte Caron, Julie Cloutier et al. · Journal of Medicinal Chemistry · 1997 · 154 citations · Full text

Pharmaceutical Science, Altmetric Attention Score, Organic Chemistry +18

Discovery of a 1<i>H</i>-Benzoimidazol-2-yl)-1<i>H</i>-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

Mark D. Wittman, Joan M. Carboni, Ricardo M. Attar et al. · Journal of Medicinal Chemistry · 2005 · 134 citations · Full text

Pharmacotherapy, Insulin Receptor, Insulin Signaling +21

Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors

Françis Beaulieu, Carl Ouellet, Edward H. Ruediger et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 53 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +12

Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors

Makonen Belema, Amy Bunker, Van N. Nguyen et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 34 citations · Full text

Medicinal Chemistry, Natural Sciences, Medicine +7

Synthesis and structure–activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution

Sylvain Gauthier, Julie Cloutier, Yves L. Dory et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2005 · 19 citations